StockTitan

@stocktitan.net

6 days ago

Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update Jasper Therapeutics (Nasdaq: JSPR) reported Q4 and full-year 2025 results and clinical updates on briquilimab, an anti‑c‑Kit antibody for chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU) and asthma. Key clinical signals: positive BEACON and open‑label extension CSU data, ETESIAN asthma proof‑of‑concept, dose selection for Phase 2b planned H2 2026. Financials: cash of $28.7M at Dec 31, 2025 and a 2025 net loss of $75.8M. Company noted Phase 2b enrollment timing is pending capital availability.

#JSPR Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update

www.stocktitan.net/news/JSPR/jasper-therape...

StockTitan

@stocktitan.net

2 months ago

Jasper Therapeutics Reports Positive Updated Data from Briquilimab Studies in Chronic Spontaneous Urticaria Jasper Therapeutics (NASDAQ: JSPR) reported updated clinical data for briquilimab in chronic spontaneous urticaria (CSU) from the randomized BEACON Phase 1b/2a study and an open‑label extension. In the BEACON 240mg→180mg Q8W cohort (briquilimab, n=6) mean UAS7 fell by 31 points at 12 weeks; 83% had UAS7=0 by week 3 and 67% had UAS7=0 at week 12. In the open‑label extension, 58% of CSU patients (n=36) achieved UAS7=0 at 12 weeks and 75% reached UAS7≤6. Median follow‑up was 205 days in 63 patients. Safety findings were infrequent, predominantly low‑grade, and no dose‑limiting toxicities were observed. Jasper said data support dose selection for a Phase 2b CSU study planned for the second half of 2026.

#JSPR Jasper Therapeutics Reports Positive Updated Data from Briquilimab Studies in Chronic Spontaneous Urticaria

www.stocktitan.net/news/JSPR/jasper-therape...

Giants67

@giants1967.bsky.social

4 months ago

$1 Stocks to Watch: JSPR, FTEL, BYND, TOON December 2025 More Inside Getting your Trinity Audio player ready... A surge of low-priced names is capturing trader attention as December 2025 opens, with several companies showing fresh catalysts, rising volume, or renewed i...

Momentum Rotates Back to the $1 Tier
thestreetreports.com/1-stocks-to-...
#APRE #TOON #PRSO #JSPR

Stock Master

@stockmaster70.bsky.social

4 months ago

📢 Stocks Trending NOW: #BYND #MDB #CRDO #PLRZ #MRVL #JSPR #ALAB #SNOW #FTEL #TAOP

StockTitan

@stocktitan.net

4 months ago

Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation Jasper Therapeutics (Nasdaq: JSPR) reported positive preliminary Phase 1b ETESIAN results for briquilimab in allergic asthma and closed an internal BEACON investigation. A single 180mg subcutaneous dose produced marked reductions in sputum eosinophils and serum tryptase and improved Early and Late Asthmatic Response (LAR %Max FEV1 +10.4% at 6 weeks, +8.7% at 12 weeks versus baseline). Briquilimab was well tolerated. The BEACON probe found no drug product issues; Jasper concluded the anomalous lack of CSU efficacy in 10 US patients likely reflected patient selection (9 of 10 likely not mast cell-driven). Jasper expects additional BEACON data in Q1 2026 and plans Phase 2b CSU dosing selection mid-2026.

#JSPR Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation

www.stocktitan.net/news/JSPR/jasper-therape...

Small Cap Strategist

@smcapstrategist.bsky.social

4 months ago

Small-cap stocks with strong volume declines, Mon Dec 1st - #TAOP #SGN #IWF #HUBC #DXST #VCIC #PRPH #JSPR #DYAI #CNEY #EVAC - More: crystalequityresearch.com/leading-indi... - #smallcap

StockTitan

@stocktitan.net

4 months ago

Jasper Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - JSPR LOS ANGELES, Nov. 14, 2025

#JSPR Jasper Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - JSPR

www.stocktitan.net/news/JSPR/jasper-therape...

StockTitan

@stocktitan.net

4 months ago

Jasper Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - JSPR LOS ANGELES, Nov. 11, 2025

#JSPR Jasper Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - JSPR

www.stocktitan.net/news/JSPR/jasper-therape...

StockTitan

@stocktitan.net

4 months ago

#JSPR Jasper Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

www.stocktitan.net/news/JSPR/jasper-therape...

Thiard News@F4F

@newsen.bsky.social

4 months ago

Opportunities for JSPR Investors in Jasper Therapeutics Fraud Lawsuit Recent updates from Rosen Law Firm inform JSPR investors about a class action lawsuit regarding securities fraud at Jasper Therapeutics. Join now to protect your rights.

Opportunities for JSPR Investors in Jasper Therapeutics Fraud Lawsuit #USA #New_York #Rosen_Law_Firm #Jasper_Therapeutics #JSPR

Thiard News@F4F

@newsen.bsky.social

4 months ago

Faruqi & Faruqi Investigates Jasper Investor Claims: Deadlines Approaching Faruqi & Faruqi, LLP is probing potential claims on behalf of Jasper investors. Contact them if you suffered losses from November 2023 to July 2025.

Faruqi & Faruqi Investigates Jasper Investor Claims: Deadlines Approaching #United_States #New_York #Faruqi_&_Faruqi #Jasper_Therapeutics #JSPR

Thiard News@F4F

@newsen.bsky.social

4 months ago

Investors Take Action Against Jasper Therapeutics for Securities Violations Jasper Therapeutics faces legal action attributed to misleading statements impacting shareholders. Learn how you can participate.

Investors Take Action Against Jasper Therapeutics for Securities Violations #United_States #Los_Angeles #Lawsuit #Jasper_Therapeutics #JSPR

StockTitan

@stocktitan.net

4 months ago

Jasper Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - JSPR LOS ANGELES, Nov. 7, 2025

#JSPR Jasper Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - JSPR

www.stocktitan.net/news/JSPR/jasper-therape...

Small Cap Strategist

@smcapstrategist.bsky.social

4 months ago

Small-cap stocks in new ADX downtrend, Thu Nov 6th - #FTFT #GYRE #HTLD #DMLP #CVAC #INGN #JSPR #BHST #KPRX #MXCT #AIOT #WDH #SITC #NPB #NOTE #MED #JBI #DEA #CNMD #BLND #SGN #KAPA #UAVS #VVPR #TRNS #RPD #PSEC - More: crystalequityresearch.com/trade-alerts... - #smallcap

Thiard News@F4F

@newsen.bsky.social

5 months ago

Investors in Jasper Therapeutics Can Now Lead a Securities Fraud Lawsuit Following Significant Losses Jasper Therapeutics investors who faced losses have the chance to spearhead a securities fraud class action lawsuit. The lawsuit alleges undisclosed risks that affected the company's prospects.

Investors in Jasper Therapeutics Can Now Lead a Securities Fraud Lawsuit Following Significant Losses #USA #Los_Angeles #Frank_R._Cruz #Jasper_Therapeutics #JSPR

Thiard News@F4F

@newsen.bsky.social

5 months ago

JSPR Investor Alert: Seek Legal Recourse for Losses Over $75,000 Investors in Jasper Therapeutics with losses exceeding $75,000 are urged to connect with legal expert James (Josh) Wilson to explore their options.

JSPR Investor Alert: Seek Legal Recourse for Losses Over $75,000 #USA #New_York #Faruqi_&_Faruqi #Jasper_Therapeutics #JSPR

Thiard News@F4F

@newsen.bsky.social

5 months ago

Investors Encouraged to Join Class Action Against Jasper Therapeutics with Schall Law Firm The Schall Law Firm invites investors in Jasper Therapeutics to participate in a class action lawsuit, aiming for accountability due to alleged fraud.

Investors Encouraged to Join Class Action Against Jasper Therapeutics with Schall Law Firm #United_States #Los_Angeles #Schall_Law_Firm #Jasper_Therapeutics #JSPR

Thiard News@F4F

@newsen.bsky.social

5 months ago

Pomerantz Law Firm Initiates Class Action Against Jasper Therapeutics for Securities Violations Jasper Therapeutics faces a class action lawsuit filed by Pomerantz LLP over alleged violations of securities laws impacting investors. Learn more about the case.

Pomerantz Law Firm Initiates Class Action Against Jasper Therapeutics for Securities Violations #USA #New_York #Pomerantz_Law_Firm #Jasper_Therapeutics #JSPR

Thiard News@F4F

@newsen.bsky.social

5 months ago

Jasper Therapeutics Faces Class Action Lawsuit for Securities Violations – What Investors Need to Know Jasper Therapeutics, Inc. is under fire due to allegations of securities law violations. The DJS Law Group invites affected investors to seek justice.

Jasper Therapeutics Faces Class Action Lawsuit for Securities Violations – What Investors Need to Know #USA #New_York #DJS_Law_Group #Jasper_Therapeutics #JSPR

Thiard News@F4F

@newsen.bsky.social

6 months ago

Pomerantz Law Firm Initiates Class Action Against Jasper Therapeutics Over Alleged Securities Violations Pomerantz LLP has filed a class action lawsuit against Jasper Therapeutics and certain officers, alleging violations of federal securities laws. This follow-up could impact investors significantly.

Pomerantz Law Firm Initiates Class Action Against Jasper Therapeutics Over Alleged Securities Violations #United_States #California #Pomerantz_LLP #Jasper_Therapeutics #JSPR

Thiard News@F4F

@newsen.bsky.social

6 months ago

Jasper Therapeutics Shareholders Can Take Legal Action Over Fraud Claims Jasper Therapeutics, Inc. investors facing losses have a chance to lead a securities fraud lawsuit. Act now before the deadline to participate.

Jasper Therapeutics Shareholders Can Take Legal Action Over Fraud Claims #United_States #Bensalem #Howard_Smith_Law #Jasper_Therapeutics #JSPR

Thiard News@F4F

@newsen.bsky.social

6 months ago

Jasper Therapeutics Faces Class Action Lawsuit for Securities Violations - What Investors Must Know Jasper Therapeutics, Inc. is undergoing a class-action lawsuit regarding securities law violations, affecting shareholders. Here's what you need to know.

Jasper Therapeutics Faces Class Action Lawsuit for Securities Violations - What Investors Must Know #United_States #Los_Angeles #DJS_Law_Group #Jasper_Therapeutics #JSPR

Thiard News@F4F

@newsen.bsky.social

6 months ago

Class Action Lawsuit Filed for Jasper Therapeutics, Inc. Securities Fraud Claims Rosen Law Firm has initiated a class action lawsuit for investors in Jasper Therapeutics, Inc. over alleged securities fraud during a specified period. Join today!

Class Action Lawsuit Filed for Jasper Therapeutics, Inc. Securities Fraud Claims #USA #New_York #Rosen_Law_Firm #Jasper_Therapeutics #JSPR

Thiard News@F4F

@newsen.bsky.social

6 months ago

Jasper Therapeutics, Inc. Faces Class Action Over Securities Law Violations Investors are encouraged to join a class action against Jasper Therapeutics for alleged securities law violations affecting shareholders from late 2023 to mid-2025.

Jasper Therapeutics, Inc. Faces Class Action Over Securities Law Violations #United_States #DJS_Law_Group #Eastchester #Jasper_Therapeutics #JSPR

Thiard News@F4F

@newsen.bsky.social

6 months ago

Jasper Therapeutics Faces Class Action Lawsuit Amid Controversies and Allegations Jasper Therapeutics, Inc. is under legal scrutiny as a class action lawsuit is filed against the biotech firm, highlighting alleged discrepancies in their product development.

Jasper Therapeutics Faces Class Action Lawsuit Amid Controversies and Allegations #USA #San_Diego #Robbins_LLP #Jasper_Therapeutics #JSPR

Thiard News@F4F

@newsen.bsky.social

6 months ago

Pomerantz LLP Launches Class Action Against Jasper Therapeutics Due to Securities Violations Pomerantz Law Firm has initiated a class action lawsuit against Jasper Therapeutics, addressing serious allegations of securities law violations affecting investors who acquired shares within a specific timeframe.

Pomerantz LLP Launches Class Action Against Jasper Therapeutics Due to Securities Violations #United_States #California #Pomerantz_Law #Jasper_Therapeutics #JSPR

Option Mike

@optionmike.bsky.social

6 months ago

Good Morning!

Futures down

#HOOD #APP enter #SPY

#AAPL pt raised $310 from $270 @ Wedbush

#LSCC pt raised $80 from $70 @ Needham
#OKLO pt raised $150 @ Wedbush
#CROX d/g Neutral @ Piper pt $75
#XEL u/g Outperform @ BMO pt $80 from $73

#JSPR pt cut $7 from $20 @ BTIG

StockTitan

@stocktitan.net

6 months ago

Jasper Therapeutics Announces Proposed Public Offering of Common Stock, Pre-Funded Warrants and Common Warrants Jasper Therapeutics (Nasdaq: JSPR), a clinical-stage biotech company, has announced a proposed public offering of common stock and warrants. The offering includes shares of common stock, pre-funded warrants, and accompanying common warrants. TD Cowen will serve as the sole book-running manager.The company plans to use the proceeds to advance the development of briquilimab, their novel antibody therapy targeting KIT (CD117). This therapy is being developed for mast cell-driven diseases including chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU), and asthma. Additional funds will support general corporate purposes, including capital expenditures and working capital.

#JSPR Jasper Therapeutics Announces Proposed Public Offering of Common Stock, Pre-Funded Warrants and Common Warrants

www.stocktitan.net/news/JSPR/jasper-therape...

StockTitan

@stocktitan.net

7 months ago

Jasper Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic

#JSPR Jasper Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

www.stocktitan.net/news/JSPR/jasper-therape...

Thiard News@F4F

@newsen.bsky.social

8 months ago

Investors Alert: Pomerantz Law Firm Probes Jasper Therapeutics for Possible Fraud Pomerantz LLP is investigating potential securities fraud involving Jasper Therapeutics, following a significant stock drop after troubling study results.

Investors Alert: Pomerantz Law Firm Probes Jasper Therapeutics for Possible Fraud #USA #New_York #Pomerantz_LLP #Jasper_Therapeutics #JSPR